Pfizer CEO Albert Bourla Acquires 21 Phantom Stock Units via Deferred Compensation Plan
PFIZER INC
Subscribe to track PFE
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Pfizer Inc. ($PFE) — Form 4 Filing Summary • Insider: Albert Bourla (Chairman & CEO) • Transaction: Acquisition of 21 Phantom Stock Units • Price: $28.46 per unit (~$597.66 total) • Post-Transaction Holdings: 784,012 units • Details: Routine acquisition under the Nonfunded Deferred Compensation and Supplemental Savings Plan. • Significance: Low
Comprehensive Analysis
Transaction Summary
Pfizer Inc. ($PFE) Chairman and CEO Albert Bourla acquired 21 Phantom Stock Units on August 31, 2026, at an effective price of $28.46 per unit, for a total value of approximately $597.66.
Filing Breakdown
- Security: Phantom Stock Units SSP (each representing one phantom share of common stock).
- Nature of Transaction: Code 'A' (Award/Acquisition) pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan.
- Settlement Terms: Units are settled in cash following separation from service and may be transferred to alternative investment accounts at any time.
- Holdings Post-Transaction: 784,012 phantom units held directly.
Market Significance
This transaction reflects routine participation in Pfizer's deferred compensation and supplemental savings program. Given the minimal size ($597.66) and administrative nature of the plan contribution, it carries low trading significance.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.